3. Aegerion Pharmaceuticals, Inc. (AEGR): Engages in the development and commercialization of novel therapeutics to treat severe lipid disorders. Market cap of $325.99M. Net insider shares purchased over the last six months at 695.15K, which is 6.14% of the company's 11.32M share float. It's been a rough couple of days for the stock, losing 5.52% over the last week.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.